These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30920079)

  • 1. Expression analysis of selected miR-206 targets from the transforming growth factor-β signaling pathway in breast cancer.
    Seifi-Alan M; Dianatpour A; Geranpayeh L; Mirfakhraie R; Omrani MD; Ghafouri-Fard S
    J Cell Biochem; 2019 Aug; 120(8):13545-13553. PubMed ID: 30920079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
    Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
    Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of long non-coding ATB and its putative target in breast cancer.
    Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S
    Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.
    Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC
    Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
    Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females.
    Ahmed F; Adnan M; Malik A; Tariq S; Kamal F; Ijaz B
    PLoS One; 2021; 16(7):e0255243. PubMed ID: 34297787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
    Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
    Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
    Petrovic N; Davidovic R; Jovanovic-Cupic S; Krajnovic M; Lukic S; Petrovic M; Roganovic J
    Mol Diagn Ther; 2016 Dec; 20(6):603-615. PubMed ID: 27488105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
    Xie R; Tang J; Zhu X; Jiang H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
    Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
    Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
    Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
    Pollari S; Leivonen SK; Perälä M; Fey V; Käkönen SM; Kallioniemi O
    PLoS One; 2012; 7(5):e37361. PubMed ID: 22629385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
    J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
    Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
    Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
    Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
    Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.